Literature DB >> 9010276

IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression.

K Ochiai1, M Kagami, R Matsumura, H Tomioka.   

Abstract

In order to determine regulatory mechanisms of eosinophil apoptosis, we examined the effect of recombinant IL-5 and interferon-gamma (IFN-gamma) on eosinophil apoptosis and bcl-2 expression. rhIL-5 (2.5 ng/ml) significantly inhibited eosinophil apoptosis in 96 h in vitro culture compared with medium only-cultured eosinophils (89.4 +/- 3.6% versus 31.3 +/- 12.2% (mean +/- s.d.); n = 7, P < 0.05). Further, rhIL-5 significantly increased bcl-2 protein and mRNA expression on cultured eosinophils. A phosphorothioate antisense oligonucleotide targeted at the ATG translation initiation codon of bcl-2 (10(-5) M) could significantly block the supportive effect of rhIL-5 (0.25 ng/ml) for eosinophil survival compared with sense cDNA of bcl-2 on 96 h culture (inhibition rate 28.01 +/- 4.56% versus 0.07 +/- 1.73%; n = 4, P < 0.05). In contrast, rhIFN-gamma (100 U/ml) significantly inhibited eosinophil apoptosis on 96 h in vitro culture (72.7 +/- 10.5%; n = 7, P < 0.05), but did not significantly up-regulate bcl-2 protein and mRNA. These results indicate that IL-5 has inhibitory effects on eosinophil apoptosis by regulation of bcl-2 expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010276      PMCID: PMC1904544          DOI: 10.1046/j.1365-2249.1997.d01-884.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2.

Authors:  H M Ogmundsdóttir; S Sveinsdóttir; A Sigfússon; I Skaftadóttir; J G Jónasson; B A Agnarsson
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma).

Authors:  K Ochiai; E Tanabe; C Ishihara; M Kagami; T Sugiyama; M Sueishi; N Koya; H Tomioka
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  Determinants of eosinophil survival and apoptotic cell death.

Authors:  Zhong-Jian Shen; James S Malter
Journal:  Apoptosis       Date:  2015-02       Impact factor: 4.677

5.  Bcl-2 expression in sputum eosinophils in patients with acute asthma.

Authors:  A S Jang; I S Choi; S Lee; J P Seo; S W Yang; C S Park
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

6.  Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils.

Authors:  J Zangrilli; N Robertson; A Shetty; J Wu; A Hastie; J E Fish; G Litwack; S P Peters
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 7.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

8.  Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils.

Authors:  K Ogawa; R Hashida; M Miyagawa; S Kagaya; Y Sugita; K Matsumoto; T Katsunuma; A Akasawa; G Tsujimoto; H Saito
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 9.  Allergic mechanisms of Eosinophilic oesophagitis.

Authors:  John Leung; Koen Robert Beukema; Alice Hangzhou Shen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-09-11       Impact factor: 3.043

10.  New and Emerging Therapies for Pediatric Atopic Dermatitis.

Authors:  Henry L Nguyen; Katelyn R Anderson; Megha M Tollefson
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.